中东和非洲透皮给药系统市场预测至 2030 年 - 区域分析 - 按类型（透皮贴剂、透皮凝胶、透皮喷雾剂等）、应用（心血管疾病、中枢神经系统疾病、疼痛管理、激素应用和其他应用）和分销渠道（医院药房、零售药房、网上药房等）
慢性病患病率不断上升促进了中东和非洲透皮给药系统市场的发展
心绞痛、动脉粥样硬化、心绞痛和急性心肌梗死等心血管疾病 (CVD) 是世界常见的死亡原因。据世界卫生组织称，心血管疾病是每年全球约 1790 万人死亡的主要原因。市面上有许多用于治疗心血管疾病的药物，但传统的胶囊和药片无法有效控制这种疾病。这凸显了对新型药物输送系统的需求，这种系统可以提供延长的药物生物利用度和向心血管系统受影响区域的靶向药物输送。透皮给药系统在治疗心血管疾病方面比常规口服药物具有许多优势。透皮贴剂包含药物颗粒，可应用于皮肤表面。心脏贴剂为细胞植入改善提供了极好的平台。例如，最近开发的血管化心脏贴剂显示出治疗缺血性心脏损伤的良好潜力。硝酸甘油透皮贴剂用于预防冠状动脉疾病患者的心绞痛（胸痛）。它们的作用是放松血管，减少心脏压力，从而降低对氧气的需求。但是，这些贴剂不能用于治疗已经开始的心绞痛发作。
利伐斯的明贴剂用于治疗与轻度、中度或重度阿尔茨海默病相关的痴呆（记忆丧失）或与帕金森病相关的轻度至中度痴呆。利伐斯的明和多奈哌齐是胆碱酯酶抑制剂，具有剂量反应关系，药物剂量越高，疗效越好。它是一种小的亲脂性和亲水性分子，在化学上非常适合透皮给药。
糖尿病是一种危及生命的慢性疾病，没有专门的治疗方法。两种类型的糖尿病都会导致身体不同部位出现各种问题，并增加过早死亡的总体风险。根据国际糖尿病联合会 (IDF) 糖尿病图谱第 10 版报告，2021 年，全球有 5.37 亿成年人 (20-79 岁) 患有糖尿病，到 2030 年这一数字可能会达到 6.43 亿，到 2045 年可能会达到 7.83 亿。外源性胰岛素通常皮下注射用于糖尿病管理。然而，最近人们开始关注一种智能贴片，它可以在需要时输送胰岛素，简化胰岛素摄入并激活有针对性的行动。
因此，心血管疾病、阿尔茨海默病和糖尿病等慢性病发病率的增加促进了透皮给药系统市场的增长。
中东和非洲透皮给药系统市场概览
中东和非洲的透皮给药系统市场分为阿联酋、沙特阿拉伯、南非和中东和非洲其他地区。由于慢性病患病率高、医疗保健支出增加以及整个地区研发活动不断增加，预计市场增长将增长。此外，对技术先进的医疗设备的需求不断增长有助于推动预测期内的市场增长。根据健康研究政策与系统于 2022 年发表的一项研究“沙特阿拉伯的非传染性疾病和卫生系统应对措施：重点关注政策和战略。一项定性研究”，非传染性疾病 (NCD)，尤其是糖尿病、心血管疾病和其他慢性病，是沙特阿拉伯疾病和经济负担增加的原因。根据沙特卫生部的统计数据，心血管疾病占沙特阿拉伯所有死亡人数的 37%。根据联合国人口基金 (UNFPA) 的数据，预计沙特阿拉伯的老龄人口将从 2020 年的 200 万 (5.9%) 增加到 2050 年的 1050 万 (23.7%)，增长 5 倍。老年人口容易患心血管疾病、肺部感染和糖尿病等健康问题。根据 2020 年发布的全球疾病负担数据，沙特阿拉伯中风、心脏病、肾病、慢性阻塞性肺病和糖尿病等非传染性疾病的发病率很高。此外，2009 年至 2019 年间，与糖尿病相关的死亡人数增加了约 79%，慢性肾病增加了 41.2%，中风增加了 27.6%。因此，上述疾病的高发病率刺激了对透皮给药系统的需求，从而促进了市场增长。
沙特阿拉伯于 2019 年与英国学术和研究机构合作，实施了一项 16 亿美元的计划，以增强该国的国内研发能力。在沙特阿拉伯，由于对医疗保健服务的需求不断增长，政府不断推出的举措有利于私营部门更多地参与其扩张。因此，沙特阿拉伯人口心血管疾病患病率的上升和医疗保健支出的上升对透皮给药系统市场的增长起着至关重要的作用。
中东和非洲透皮给药系统市场收入和预测到 2030 年（百万美元）
中东和非洲透皮给药系统市场细分
中东和非洲透皮给药系统市场细分为类型、应用、分销渠道和国家。
根据类型，中东和非洲透皮给药系统市场细分为透皮贴剂、透皮凝胶、透皮喷雾剂等。透皮凝胶部分在 2022 年占据了中东和非洲透皮给药系统市场的最大份额。透皮贴剂进一步细分为药物粘合剂贴剂、基质贴剂、储库膜贴剂和蒸汽贴剂。
在应用方面，中东和非洲透皮给药系统市场分为心血管疾病、中枢神经系统疾病、疼痛管理、激素应用和其他应用。疼痛管理部分在 2022 年占据了中东和非洲透皮给药系统市场的最大份额。疼痛管理进一步细分为阿片类药物和非阿片类药物。激素应用进一步细分为透皮雌激素和孕激素治疗和睾酮替代。
按分销渠道，中东和非洲透皮给药系统市场细分为医院药房、零售药房、在线药房和其他。医院药房部分在 2022 年占据了中东和非洲透皮给药系统市场的最大份额。
根据国家/地区，中东和非洲透皮给药系统市场分为阿联酋、沙特阿拉伯、南非和中东及非洲其他地区。 2022 年，沙特阿拉伯在中东和非洲透皮给药系统市场占据主导地位。
勃林格殷格翰国际有限公司、葛兰素史克公司、久光制药有限公司、强生公司、诺华公司和 Viatris Inc 是中东和非洲透皮给药系统市场的一些领先公司。
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Transdermal Drug Delivery System Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
4.1.3 High Demand for Self-Administration of Drugs
4.2 Market Restraints
4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
4.3 Market Opportunities
4.3.1 Advancements in Smart Patches and 3D-Printed Patches
4.4 Future Trends
4.4.1 Strategic Initiatives by Manufacturers
4.5 Impact Analysis
5. Transdermal Drug Delivery System Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030
6. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type
6.1 Overview
6.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Transdermal Patches
6.3.1 Overview
6.3.2 Transdermal Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Drug-in-Adhesive Patches
6.3.2.1.1 Overview
6.3.2.1.2 Drug-in-Adhesive Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Matrix Patches
6.3.2.2.1 Overview
6.3.2.2.2 Matrix Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Reservoir Membrane Patches
6.3.2.3.1 Overview
6.3.2.3.2 Reservoir Membrane Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.4 Vapor Patches
6.3.2.4.1 Overview
6.3.2.4.2 Vapor Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Transdermal Gels
6.4.1 Overview
6.4.2 Transdermal Gels: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Transdermal Sprays
6.5.1 Overview
6.5.2 Transdermal Sprays: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cardiovascular Diseases
7.3.1 Overview
7.3.2 Cardiovascular Diseases: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Central Nervous System Disorders
7.4.1 Overview
7.4.2 Central Nervous System Disorders: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Pain Management
7.5.1 Overview
7.5.2 Pain Management: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Opioid
7.5.2.1.1 Overview
7.5.2.1.2 Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.2 Non-Opioid
7.5.2.2.1 Overview
7.5.2.2.2 Non-Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hormonal Applications
7.6.1 Overview
7.6.2 Hormonal Applications: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Transdermal Estrogen & Progesterone Therapy
7.6.2.1.1 Overview
7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.2 Testosterone Replacement
7.6.2.2.1 Overview
7.6.2.2.2 Testosterone Replacement: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Other Application
7.7.1 Overview
7.7.2 Other Application: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis
9.1 Middle East & Africa Transdermal Drug Delivery System Market
9.1.1 Middle East & Africa Transdermal Drug Delivery System Market, by Country
9.1.1.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.3 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.1.3.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.1.4 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.1.4.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.1.4.2 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.1.5 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.3 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.2.3.1 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.2.4 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.2.4.1 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.2.4.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.2.5 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.3 UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.3 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.3.3.1 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.3.4 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.3.4.1 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.3.4.2 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.3.5 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.4 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.4.3.1 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.4.4.2 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Transdermal Drug Delivery System Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Transdermal Drug Delivery System Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Johnson & Johnson
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GSK Plc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Viatris Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Boehringer Ingelheim International GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Transdermal Drug Delivery System Market Segmentation
Table 2. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 4. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 15. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 16. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 18. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 27. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 28. Glossary of Terms, Middle East & Africa Transdermal Drug Delivery System Market
?
List of Figures
Figure 1. Middle East & Africa Transdermal Drug Delivery System Market Segmentation, By Country
Figure 2. Middle East & Africa Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 3. Middle East & Africa Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Transdermal Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Drug-in-Adhesive Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Matrix Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Reservoir Membrane Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vapor Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Transdermal Gels: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Transdermal Sprays: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cardiovascular Diseases: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Central Nervous System Disorders: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Pain Management: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Non-Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Hormonal Applications: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Transdermal Estrogen & Progesterone Therapy: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Testosterone Replacement: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Other Application: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 25. Hospital Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Middle East & Africa Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Middle East & Africa Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 31. South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Transdermal Drug Delivery System Market
1. Boehringer Ingelheim International GmbH
2. GSK Plc
3. Hisamitsu Pharmaceutical Co Inc
4. Johnson & Johnson
5. Novartis AG
6. Viatris Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Transdermal Drug Delivery System Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Transdermal Drug Delivery System Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.